OncoTargets and Therapy
Volume 16, 2023 - Issue
Open access
486
Views
1
CrossRef citations to date
0
Altmetric
REVIEW
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives
John Maher1 King’s College London, School of Cancer and Pharmaceutical Sciences, CAR Mechanics Lab, Guy’s Cancer Centre, Great Maze Pond, London, SE1 9RT, UK;2 Leucid Bio Ltd., Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UK;3 Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourne, East Sussex, BN21 2UD, UKCorrespondence[email protected] [email protected]
https://orcid.org/0000-0001-8275-8488
Pages 515-532
|
Received 16 Apr 2023, Accepted 27 Jun 2023, Published online: 03 Jul 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.